BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain N, Kalam H, Singh L, Sharma V, Kedia S, Das P, Ahuja V, Kumar D. Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis. Nat Commun. 2020;11:3062. [PMID: 32546788 DOI: 10.1038/s41467-020-16877-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Alemnew B, Hoff ST, Abebe T, Abebe M, Aseffa A, Howe R, Wassie L. Ex vivo mRNA expression of toll-like receptors during latent tuberculosis infection. BMC Immunol 2021;22:9. [PMID: 33509080 DOI: 10.1186/s12865-021-00400-4] [Reference Citation Analysis]
2 Mishra R, Yadav V, Guha M, Singh A. Heterogeneous Host-Pathogen Encounters Coordinate Antibiotic Resilience in Mycobacterium tuberculosis. Trends Microbiol 2021;29:606-20. [PMID: 33309526 DOI: 10.1016/j.tim.2020.10.013] [Reference Citation Analysis]
3 Sharma A, Chakraborty A, Jaganathan BG. Review of the potential of mesenchymal stem cells for the treatment of infectious diseases. World J Stem Cells 2021; 13(6): 568-593 [PMID: 34249228 DOI: 10.4252/wjsc.v13.i6.568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pathak L, Das B. Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells. Front Immunol 2020;11:594572. [PMID: 33584661 DOI: 10.3389/fimmu.2020.594572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Brügger M, Démoulins T, Barut GT, Zumkehr B, Oliveira Esteves BI, Mehinagic K, Haas Q, Schögler A, Rameix-Welti MA, Eléouët JF, Moehrlen U, Marti TM, Schmid RA, Summerfield A, Posthaus H, Ruggli N, Hall SRR, Alves MP. Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection. PLoS Pathog 2021;17:e1009789. [PMID: 34320038 DOI: 10.1371/journal.ppat.1009789] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hao M, Xia H, Duan J, Zhou H, Zhang G, Li D, Chen X, Wang W, Sang Y, Feng S, Liu H. A Living Material Constructed from Stem Cells for Tumor‐Tropic Oncotherapy with Real‐Time Imaging. Adv Funct Materials 2022;32:2201013. [DOI: 10.1002/adfm.202201013] [Reference Citation Analysis]
7 Lin H, Yang C, Luo Y, Ge M, Shen H, Zhang X, Shi J. Biomimetic Nanomedicine-Triggered in Situ Vaccination for Innate and Adaptive Immunity Activations for Bacterial Osteomyelitis Treatment. ACS Nano 2022. [PMID: 35316599 DOI: 10.1021/acsnano.1c11132] [Reference Citation Analysis]
8 Zhang X, Xie Q, Ye Z, Li Y, Che Z, Huang M, Zeng J. Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities. Front Immunol 2021;12:695278. [PMID: 34367155 DOI: 10.3389/fimmu.2021.695278] [Reference Citation Analysis]
9 Allué-Guardia A, García JI, Torrelles JB. Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Front Microbiol 2021;12:612675. [PMID: 33613483 DOI: 10.3389/fmicb.2021.612675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]